A MULTI-CENTER, DOUBLE-DUMMY, DOUBLE-BLIND STUDY OF SUBCUTANEOUS (SC) ABATACEPT (ABA) COMPARED WITH INTRAVENEOUS (IV) ABA IN JAPANESE RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO METHOTREXATE

被引：3
|
作者：
Matsubara, T. [1 ]
Inoue, H. [2 ]
Iwahashi, M. [3 ]
Yamazaki, A. [4 ]
Takeuchi, T. [5 ]
机构：
[1] Matsubara Mayflower Hosp, Dept Orthoped, Kato, Japan
[2] Inoue Hosp, Takasaki, Gunma, Japan
[3] Higashihiroshima Mem Hosp, Hiroshima, Japan
[4] Bristol Myers KK, Clin Strategy, Tokyo, Japan
[5] Keio Univ, Dept Rheumatol, Tokyo, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 71卷
关键词：
D O I：
10.1136/annrheumdis-2012-eular.2090
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：197 / 197
页数：1
相关论文
共 50 条
  • [11] A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib to Placebo and to Adalimumab, in Patients with Active Rheumatoid Arthritis with Inadequate Response to Methotrexate
    Fleischmann, Roy
    Pangan, Aileen L.
    Mysler, Eduardo
    Bessette, Louis
    Peterfy, Charles
    Durez, Patrick
    Ostor, Andrew
    Li, Yihan
    Zhou, Yijie
    Othman, Ahmed A.
    Song, In-Ho
    Genovese, Mark C.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [12] Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate
    Schiff, M.
    Keiserman, M.
    Codding, C.
    Songcharoen, S.
    Berman, A.
    Nayiager, S.
    Saldate, C.
    Li, T.
    Aranda, R.
    Becker, J-C
    Lin, C.
    Cornet, P. L. N.
    Dougados, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (08) : 1096 - 1103
  • [13] THE EFFICACY AND SAFETY OF SUBCUTANEOUS (SC) ABATACEPT (ABA) IS CONSISTENT WITH THE ESTABLISHED INTRAVENOUS (IV) PROFILE IN A STUDY OF 1457 PATIENTS WITH RA AND AN INADEQUATE RESPONSE TO MTX (MTX-IR)
    Nash, P.
    Genovese, M.
    Covarrubias, J.
    Leon, G.
    Mysler, E.
    Keiserman, M.
    Valante, R.
    Simon, J.
    Porawska, W.
    Box, J.
    Leggerton, C.
    Nasonov, E.
    Durez, P.
    Aranda, R.
    Pappau, R.
    Delaet, I
    Teng, J.
    Alten, R.
    Bamford, T.
    INTERNAL MEDICINE JOURNAL, 2011, 41 : 16 - 16
  • [14] FLURBIPROFEN AND INDOMETHACIN IN RHEUMATOID-ARTHRITIS AND OSTEOARTHROSIS OF THE KNEE - A COMPARATIVE MULTI-CENTER DOUBLE-BLIND CROSSOVER STUDY
    PILGER, A
    BACH, GL
    MULLERFASSBENDER, H
    REITER, W
    EBERHARDT, R
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 1981, 40 (02): : 87 - 92
  • [15] Efficacy of abatacept or infliximab treatment in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a 1-year double-blind, randomized, placebo-controlled trial
    Bessette, L.
    Homik, J.
    Dougados, M.
    Keiserman, M.
    Codding, C.
    Songcharoen, S.
    Berman, A.
    Nayiager, S.
    Saldate, C.
    Aranda, R.
    Becker, J.
    Li, T.
    Lin, C.
    Cornet, P. L. N.
    Schiff, M.
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (06) : 1178 - 1179
  • [16] Efficacy of abatacept or infliximab treatment in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a 1-year double-blind, randomized, placebo-controlled trial
    Dougados, M.
    Keiserman, M.
    Codding, C.
    Songcharoen, S.
    Berman, A.
    Nayiager, S.
    Saldate, C.
    Aranda, R.
    Becker, J.
    Li, T.
    Lin, C.
    Cornet, R. L. N.
    Schiff, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 88 - 88
  • [17] Safety and Efficacy of Various Dosages of Ocrelizumab in Japanese Patients with Rheumatoid Arthritis with an Inadequate Response to Methotrexate Therapy: A Placebo-controlled Double-blind Parallel-group Study
    Harigai, Masayoshi
    Tanaka, Yoshiya
    Maisawa, Shingo
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (03) : 486 - 495
  • [18] Effectiveness of Abatacept or infliximab in patients with rheumatoid arthritis and insufficient response to methotrexate: Results of a randomised, double-blind placebo-controlled study over one year
    Altmann, M.
    Dougados, M.
    Keiserman, M.
    Aranda, R.
    Becker, J.
    Li, T.
    Schiff, M.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2007, 66 : 78 - 78
  • [19] A double-blind, randomized, 6 arm, parallel-group, dose finding, double-dummy, multi-center comparison of sTNFr55-IgG (Ro 45-2081-Lenercept [LEN]) subcutaneous (SC) to reference treatment with oral methotrexate (MTX) and their combination in patients with rheumatoid arthritis (RA) (12 week dose-finding efficacy/safety study)
    McKay, J
    Rau, R
    Weisman, M
    Stevens, RM
    Zaug, M
    Van der Auwera, P
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S132 - S132
  • [20] The clinical efficacy and safety of subcutaneous (s.c.) versus oral application of methotrexate (MTX) in patients with active rheumatoid arthritis (RA) -: Results of a randomized, controlled, double-blind, multi-center study.
    Braun, J
    Kästner, P
    Flaxenberg, P
    Währisch, J
    Hanke, P
    Demary, W
    von Hinüber, U
    Rockwitz, K
    Heitz, W
    Pichlmeier, U
    Brandt, A
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S542 - S542
12345